Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib and/or Lenalidomide Maintenance in NDMM
NCT04217967Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2019
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ixazomib in multiple myeloma (MM), sponsored by Peking Union Medical College Hospital. Started Sep 2019; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04217967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04217967.